LAVYX
Price
$16.18
Change
+$0.11 (+0.68%)
Updated
Jul 3 closing price
Net Assets
2B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAVYX vs VVIAX

Header iconLAVYX vs VVIAX Comparison
Open Charts LAVYX vs VVIAXBanner chart's image
Lord Abbett Fundamental Equity I
Price$16.18
Change+$0.11 (+0.68%)
VolumeN/A
Net Assets2B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LAVYX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVYX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVYX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LAVYX (2B). VVIAX pays higher dividends than LAVYX: VVIAX (2.18) vs LAVYX (1.02). LAVYX was incepted earlier than VVIAX: LAVYX (22 years) vs VVIAX (25 years). LAVYX (0.70) is less costly to investors than VVIAX (0.05). LAVYX is a more actively managed with annual turnover of: 39.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than LAVYX: VVIAX (3000) vs LAVYX (1000000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. LAVYX (9.47). VVIAX return over 5 years is better than : 80.13 vs. LAVYX (61.89).
LAVYXVVIAXLAVYX / VVIAX
Total Expense Ratio0.700.051,400%
Annual Report Gross Expense Ratio0.700.051,400%
Fund Existence22 years25 years-
Gain YTD6.5176.198105%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2B189B1%
Annual Yield % from dividends1.022.1847%
Returns for 1 year9.4712.0379%
Returns for 3 years39.3635.17112%
Returns for 5 years61.8980.1377%
Returns for 10 years29.48115.6725%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.